During the past 3 years, the average Total Assets Growth Rate was 40.50% per year.
During the past 5 years, the average Total Assets Growth Rate was 27.80% per year.
During the past 10 years, the average Total Assets Growth Rate was 16.50% per year.
During the past 11 years, Gongwin Biopharm Holdings Co's highest 3-Year average Total Assets Growth Rate was 40.50%. The lowest was 0.50%. And the median was 18.25%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gongwin Biopharm Holdings Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gongwin Biopharm Holdings Co (ROCO:6617) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Gongwin Biopharm Holdings Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Gongwin Biopharm Holdings Co Total Assets Related Terms
Thank you for viewing the detailed overview of Gongwin Biopharm Holdings Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Gongwin Biopharm Holdings Co (ROCO:6617) Business Description
Gongwin Biopharm Holdings Co Ltd is a Taiwanese biotech and pharmaceutical company engaged in research and development of anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma.
Gongwin Biopharm Holdings Co (ROCO:6617) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:6617 has been successfully added to your 